Related Experiment Video
Updated: Dec 8, 2025

12:57
Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
16.3K
Tau proteinopathies and the prion concept
1MRC Laboratory Molecular Biology, Cambridge, United Kingdom.
Progress in Molecular Biology and Translational Science
|September 22, 2020
Summary
Protein assemblies like tau form prions in neurodegenerative diseases. Distinct tau structures, or conformers, are found in different diseases, offering disease-specific insights.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Amyloid filaments formed by protein aggregates are implicated in age-related neurodegenerative diseases.
- Tau protein is frequently involved, with its abnormal assembly contributing to disease progression.
- These tau assemblies spread through the brain, causing disease symptoms.
Purpose of the Study:
- To investigate the prion-like behavior of assembled tau.
- To characterize the structural diversity of tau filaments in different neurodegenerative diseases.
Main Methods:
- Analysis of electron cryo-microscopy data of tau filaments.
- Comparison of tau filament structures across various disease states.
Main Results:
- Evidence supports that assembled tau acts as a prion.
- Distinct tau conformers were identified in different diseases.
- No variation in tau conformation was observed within individuals for a specific disease.
Conclusions:
- Assembled tau exhibits prion-like properties, driving neurodegeneration.
- Disease-specific tau conformers represent potential diagnostic or therapeutic targets.
- Structural uniformity of tau within a disease suggests a common pathogenic mechanism.
Related Concept Videos
Amyloid Fibrils
11.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.4K
Amyloid Fibrils
6.2K
6.2K
Subviral Agents
350
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
350
Cotranslational Protein Translocation
9.1K
Translocation of proteins across membranes is an ancient process that occurs even in bacteria and archaebacteria. In fact, the components of the translocation machinery are still conserved between prokaryotes and eukaryotes.
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
9.1K
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
The Proteasome
9.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.8K

